Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

H. J. Schmoll, E. Van cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, B. Nordlinger, C. J. Van de Velde, J. Balmana, J. Regula, I. D. Nagtegaal, R. G. Beets-Tan, D. Arnold, F. Ciardiello, P. Hoff, D. Kerr, C. H. Köhne, R. Labianca, T. Price, W. ScheithauerA. Sobrero, J. Tabernero, D. Aderka, S. Barroso, G. Bodoky, J. Y. Douillard, H. El ghazaly, J. Gallardo, A. Garin, R. Glynne-jones, K. Jordan, A. Meshcheryakov, D. Papamichail, P. Pfeiffer, I. Souglakos, S. Turhal, A. Cervantes

Research output: Contribution to journalArticle

746 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

Original languageEnglish
Article numbermds236
Pages (from-to)2479-2516
Number of pages38
JournalAnnals of Oncology
Volume23
Issue number10
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Rectal Neoplasms
Colonic Neoplasms
Guidelines
Colorectal Neoplasms
Therapeutics
Occult Blood
Survival
Mortality
Hematologic Tests
Colonoscopy
Combination Drug Therapy
Clinical Decision-Making
Neoplasms
Quality of Life

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Schmoll, H. J., Van cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., ... Cervantes, A. (2012). Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Annals of Oncology, 23(10), 2479-2516. [mds236]. https://doi.org/10.1093/annonc/mds236

Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. / Schmoll, H. J.; Van cutsem, E.; Stein, A.; Valentini, V.; Glimelius, B.; Haustermans, K.; Nordlinger, B.; Van de Velde, C. J.; Balmana, J.; Regula, J.; Nagtegaal, I. D.; Beets-Tan, R. G.; Arnold, D.; Ciardiello, F.; Hoff, P.; Kerr, D.; Köhne, C. H.; Labianca, R.; Price, T.; Scheithauer, W.; Sobrero, A.; Tabernero, J.; Aderka, D.; Barroso, S.; Bodoky, G.; Douillard, J. Y.; El ghazaly, H.; Gallardo, J.; Garin, A.; Glynne-jones, R.; Jordan, K.; Meshcheryakov, A.; Papamichail, D.; Pfeiffer, P.; Souglakos, I.; Turhal, S.; Cervantes, A.

In: Annals of Oncology, Vol. 23, No. 10, mds236, 10.2012, p. 2479-2516.

Research output: Contribution to journalArticle

Schmoll, HJ, Van cutsem, E, Stein, A, Valentini, V, Glimelius, B, Haustermans, K, Nordlinger, B, Van de Velde, CJ, Balmana, J, Regula, J, Nagtegaal, ID, Beets-Tan, RG, Arnold, D, Ciardiello, F, Hoff, P, Kerr, D, Köhne, CH, Labianca, R, Price, T, Scheithauer, W, Sobrero, A, Tabernero, J, Aderka, D, Barroso, S, Bodoky, G, Douillard, JY, El ghazaly, H, Gallardo, J, Garin, A, Glynne-jones, R, Jordan, K, Meshcheryakov, A, Papamichail, D, Pfeiffer, P, Souglakos, I, Turhal, S & Cervantes, A 2012, 'Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making', Annals of Oncology, vol. 23, no. 10, mds236, pp. 2479-2516. https://doi.org/10.1093/annonc/mds236
Schmoll, H. J. ; Van cutsem, E. ; Stein, A. ; Valentini, V. ; Glimelius, B. ; Haustermans, K. ; Nordlinger, B. ; Van de Velde, C. J. ; Balmana, J. ; Regula, J. ; Nagtegaal, I. D. ; Beets-Tan, R. G. ; Arnold, D. ; Ciardiello, F. ; Hoff, P. ; Kerr, D. ; Köhne, C. H. ; Labianca, R. ; Price, T. ; Scheithauer, W. ; Sobrero, A. ; Tabernero, J. ; Aderka, D. ; Barroso, S. ; Bodoky, G. ; Douillard, J. Y. ; El ghazaly, H. ; Gallardo, J. ; Garin, A. ; Glynne-jones, R. ; Jordan, K. ; Meshcheryakov, A. ; Papamichail, D. ; Pfeiffer, P. ; Souglakos, I. ; Turhal, S. ; Cervantes, A. / Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. In: Annals of Oncology. 2012 ; Vol. 23, No. 10. pp. 2479-2516.
@article{c17d987e2c88438eb5cbd25bc723ca29,
title = "Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making",
abstract = "Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.",
author = "Schmoll, {H. J.} and {Van cutsem}, E. and A. Stein and V. Valentini and B. Glimelius and K. Haustermans and B. Nordlinger and {Van de Velde}, {C. J.} and J. Balmana and J. Regula and Nagtegaal, {I. D.} and Beets-Tan, {R. G.} and D. Arnold and F. Ciardiello and P. Hoff and D. Kerr and K{\"o}hne, {C. H.} and R. Labianca and T. Price and W. Scheithauer and A. Sobrero and J. Tabernero and D. Aderka and S. Barroso and G. Bodoky and Douillard, {J. Y.} and {El ghazaly}, H. and J. Gallardo and A. Garin and R. Glynne-jones and K. Jordan and A. Meshcheryakov and D. Papamichail and P. Pfeiffer and I. Souglakos and S. Turhal and A. Cervantes",
year = "2012",
month = "10",
doi = "10.1093/annonc/mds236",
language = "English",
volume = "23",
pages = "2479--2516",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

AU - Schmoll, H. J.

AU - Van cutsem, E.

AU - Stein, A.

AU - Valentini, V.

AU - Glimelius, B.

AU - Haustermans, K.

AU - Nordlinger, B.

AU - Van de Velde, C. J.

AU - Balmana, J.

AU - Regula, J.

AU - Nagtegaal, I. D.

AU - Beets-Tan, R. G.

AU - Arnold, D.

AU - Ciardiello, F.

AU - Hoff, P.

AU - Kerr, D.

AU - Köhne, C. H.

AU - Labianca, R.

AU - Price, T.

AU - Scheithauer, W.

AU - Sobrero, A.

AU - Tabernero, J.

AU - Aderka, D.

AU - Barroso, S.

AU - Bodoky, G.

AU - Douillard, J. Y.

AU - El ghazaly, H.

AU - Gallardo, J.

AU - Garin, A.

AU - Glynne-jones, R.

AU - Jordan, K.

AU - Meshcheryakov, A.

AU - Papamichail, D.

AU - Pfeiffer, P.

AU - Souglakos, I.

AU - Turhal, S.

AU - Cervantes, A.

PY - 2012/10

Y1 - 2012/10

N2 - Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

AB - Colorectal cancer (CRC) is the most common tumour type in both sexes combined in Western countries. Although screening programmes including the implementation of faecal occult blood test and colonoscopy might be able to reduce mortality by removing precursor lesions and by making diagnosis at an earlier stage, the burden of disease and mortality is still high. Improvement of diagnostic and treatment options increased staging accuracy, functional outcome for early stages as well as survival. Although high quality surgery is still the mainstay of curative treatment, the management of CRC must be a multi-modal approach performed by an experienced multi-disciplinary expert team. Optimal choice of the individual treatment modality according to disease localization and extent, tumour biology and patient factors is able to maintain quality of life, enables long-term survival and even cure in selected patients by a combination of chemotherapy and surgery. Treatment decisions must be based on the available evidence, which has been the basis for this consensus conference-based guideline delivering a clear proposal for diagnostic and treatment measures in each stage of rectal and colon cancer and the individual clinical situations. This ESMO guideline is recommended to be used as the basis for treatment and management decisions.

UR - http://www.scopus.com/inward/record.url?scp=84867122727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867122727&partnerID=8YFLogxK

U2 - 10.1093/annonc/mds236

DO - 10.1093/annonc/mds236

M3 - Article

C2 - 23012255

AN - SCOPUS:84867122727

VL - 23

SP - 2479

EP - 2516

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

M1 - mds236

ER -